Annual savings from FDA generic drug approvals have reached $445 billion in 2023, with year-to-year variations driven by patent expirations of blockbuster drugs. This breakdown shows how generic competition cuts drug costs across the U.S. healthcare system.
Read More
RSV Infections: What Parents and Caregivers Need to Know About Risks and Prevention
Sexual Side Effects from Antidepressants: What Works and What Doesn’t
Subclinical Hypothyroidism: When to Treat Elevated TSH Levels Safely
How the U.S. Government Is Responding to Drug Shortages: Federal Actions in 2026
Fiber Supplements and Constipation: When to Take Them With Medications
